Harris Correct That Trump Fell Short on Promise To Negotiate Medicare Drug Prices
The former president instead favored a temporary model that could’ve brought down prices of some prescription drugs, but it was blocked by the courts.
Trump Administration
641-660 of 1,297 results
-
-
How Minnesota Figures Into the Presidential Politics of Insulin Prices
Minnesota led the way on insulin affordability, culminating in 2020 when Gov. Tim Walz signed a law going further to cut costs than other state laws. Now, former President Donald Trump and Vice President Kamala Harris are vying for support from people with diabetes.
-
Vance Rewrites History About Trump and Obamacare
During the Trump administration, enrollment in Affordable Care Act health plans fell by more than 2 million people and the number of uninsured Americans rose.
-
Trump, Harris Spar Over Abortion Rights and Obamacare in Their First Face-Off
The generally combative face-off was marked by a series of false and sometimes bizarre statements from former President Donald Trump.
-
-
For Pharma, Trump vs. Harris Is a Showdown Between Two Industry Foes
Vice President Kamala Harris is seen as more aggressive than former President Donald Trump in taking on pharmaceutical companies, but Trump allies say he would also make lowering drug costs a top priority.
-
Trump Drastically Inflates Annual Fentanyl Death Numbers
The former president’s claim of 300,000 annual opioid deaths contradicts government statistics.
-
Biden Administration Blocks Two Private Sector Enrollment Sites From ACA Marketplace
Regulators have been under the gun to curb unauthorized Obamacare enrollment and switching of plans. Separately, a pending lawsuit was amended with additional defendants and new allegations regarding tactics to garner greater ACA sales commissions.
-
Harris Did Not Vote To ‘Cut Medicare,’ Despite Trump’s Claim
Former President Donald Trump’s claim that Vice President Kamala Harris voted to “cut Medicare” is false, experts say.
-
New Lines of Attack Form Against the Affordable Care Act
While fighting potential fraud in government programs has long been a conservative rallying cry, recent criticisms of the Affordable Care Act represent a renewed line of attack on the program when repealing it is unlikely.
-
Inside Project 2025: Former Trump Official Outlines Hard Right Turn Against Abortion
Former President Donald Trump has distanced himself from a Heritage Foundation document that outlines positions on abortion and a range of other social issues. But Democrats view it as a window into the far right’s to-do list and a clear opening for political attack.
-
At Trump’s GOP Convention, There’s Little To Be Heard on Health Care
Republicans were once the party of Obamacare repeal and abortion opposition. They’ve said little about either issue in Milwaukee.
At GOP Convention, Health Policy Is Mostly MIA
Episode 356After an assassination attempt last weekend sent former President Donald Trump to the hospital with minor injuries, the Republican National Convention went off with little mention of health care issues. And Trump’s newly nominated vice presidential pick, Sen. J.D. Vance of Ohio, has barely staked out a record on health during his 18 months in office — aside from being strongly opposed to abortion. Alice Miranda Ollstein of Politico, Sarah Karlin-Smith of the Pink Sheet, and Joanne Kenen of Johns Hopkins University and Politico Magazine join KFF Health News’ Julie Rovner to discuss these stories and more. Also this week, Rovner interviews KFF Health News’ Renuka Rayasam, who wrote June’s installment of KFF Health News-NPR “Bill of the Month,” about a patient who walked into what he thought was an urgent care center and walked out with an emergency room bill.
-
Trump Is Wrong in Claiming Full Credit for Lowering Insulin Prices
Though the Trump administration established a voluntary, temporary program lowering insulin costs for some older Americans on Medicare, the mandatory price caps implemented through Biden’s Inflation Reduction Act go significantly further.
-
Abortion and the 2024 Election: A Video Primer
The first presidential election since the Supreme Court overturned Roe v. Wade two years ago takes place in November, and abortion is sure to play a key role.
By Julie Rovner and Rachana Pradhan SCOTUS Ruling Strips Power From Federal Health Agencies
Episode 353In what will certainly be remembered as a landmark decision, the Supreme Court has overruled a 40-year-old precedent that gave federal agencies, rather than judges, the power to interpret ambiguous laws passed by Congress. Administrative experts say the decision will dramatically change the way key health agencies do business. Also, the court decided not to decide whether a federal law requiring hospitals to provide emergency care overrides Idaho’s near-total ban on abortion. Alice Miranda Ollstein of Politico, Victoria Knight of Axios, and Joanne Kenen of Johns Hopkins University and Politico Magazine join KFF Health News chief Washington correspondent Julie Rovner to discuss these stories and more. Plus, for “extra credit,” the panelists suggest health policy stories they read this week they think you should read, too.
-
1st Biden-Trump Debate of 2024: What They Got Wrong, and Right
A debate marked by President Joe Biden’s faltering performance featured clashes over insulin costs, inflation, abortion, immigration, and Jan. 6.
Live From Aspen: Health and the 2024 Elections
Episode 352Health policy may not be the top issue in this year’s presidential and congressional elections, but it’s likely to play a key role. President Joe Biden and Democrats intend to hold Republicans responsible for the Supreme Court’s unpopular ruling overturning the right to abortion, and former President Donald Trump aims to take credit for government efforts to lower prescription drug prices — even in cases in which he played no role. Meanwhile, some critical health care issues, such as those involving Medicaid and the Affordable Care Act, are unlikely to get discussed much, even though the party in power after the elections would control the future of those programs. This week, in an episode taped before a live audience at the Aspen Ideas: Health festival in Aspen, Colorado, Margot Sanger-Katz of The New York Times and Sandhya Raman of CQ Roll Call join KFF Health News’ Julie Rovner to discuss these issues and more.
SCOTUS Rejects Abortion Pill Challenge — For Now
Episode 351The Supreme Court has dismissed a challenge to the FDA’s approval of the abortion pill mifepristone, ruling unanimously that the anti-abortion doctor group that filed the suit lacked standing. But abortion opponents are expected to pursue other strategies to ban or restrict the medication. Meanwhile, the Biden administration moves to stop the inclusion of medical debt on individual credit reports, and former President Donald Trump tries to claim credit for $35 insulin. Anna Edney of Bloomberg News, Rachana Pradhan of KFF Health News, and Emmarie Huetteman of KFF Health News join KFF Health News chief Washington correspondent Julie Rovner to discuss these stories and more. Also this week, Rovner interviews KFF president and CEO Drew Altman about KFF’s new “Health Policy 101” primer.
-
Biden’s on Target About What Repealing ACA Would Mean for Preexisting Condition Protections
A Biden campaign ad highlighting how an Obamacare repeal would affect people with preexisting conditions is mostly true.